References
- Basaga H, Poli G, Tekkaya C, Aras I. Free radical scavenging and antioxidative properties of ‘silibin’ complexes on microsomal lipid peroxidation. Cell Biochemistry and Function 1997; 15: 27–33
- Bordji K, Grillasca J-P, Gouze J-N, Magdalou J, Schohn H, Keller JM, Bianchi A, Dauţa M, Netter P, Terlain B. Evidence for the presence of peroxisome proliferator-activated receptor (PPAR) α and γ and retinoid Z receptor in cartilage. PPARgamma activation modulates the effects of interleukin-1beta on rat chondrocytes. Journal of Biological Chemistry 2000; 275: 12243–12250
- Desvergne B, Wahli W. Peroxisome proliferator-activated receptors: Nuclear control of metabolism. Endocrine Reviews 1999; 20: 649–688
- Desvergne B, Michalik L, Wahli W. Transcriptional regulation of metabolism. Physiological Reviews 2006; 86: 465–514
- Frederiksen KS, Wulf EM, Wassermann K, Sauerberg P, Fleckner J. Identification of hepatic transcriptional changes in insulin-resistant rats treated with peroxisome proliferator activated receptor-alpha agonists. Journal of Molecular Endocrinology 2003; 30: 317–329
- Gustafsson J-A. Fatty acids in control of gene expression. Nutrition Reviews 1998; 56: 20–21
- Havel RJ, Eder HA, Bragdon JH. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. Journal of Clinical Investigation 1955; 34: 1345–1353
- Haubenwallner S, Essenburg AD, Barnett BC, Pape ME, DeMattos RB, Krause BR, Minton LL, Auerbach BJ, Newton RS, Leff T, et al. Hypolipidemic activity of select fibrates correlates to changes in hepatic apolipoprotein C-III expression: A potential physiologic basis for their mode of action. Journal of Lipid Research 1995; 36: 2541–2551
- Haug A, Hostmark AT. Lipoprotein lipases, lipoproteins and tissue lipids in rats fed fish oil or coconut oil. Journal of Nutrition 1987; 117: 1011–1017
- Hunt MC, Yang YZ, Eggertsen G, Carneheim CM, Gåfvels M, Einarsson C, Alexson SEH. The peroxisome proliferator-activated receptor a (PPARa) regulates bile acid biosynthesis. Journal of Biological Chemistry 2000; 275: 28947–28953
- Johnson EF, Palmer CNA, Griffin KJ, Hsu M-H. Role of the peroxisome proliferator-activated receptor in cytochrome P450 4A gene regulation. The FASEB Journal 1996; 10: 1241–1248
- Krečman V, Škottová N, Walterová D, Ulrichová J, Šimánek V. Silymarin inhibits the development of diet-induced hypercholesterolemia in rats. Planta Medica 1998; 64: 138–142
- Latruffe N, Cherkaoui Malki M, Nicolas-Frances V, Clemencet MC, Jannin B, Berlot JP. Regulation of the peroxisomal beta-oxidation-dependent pathway by peroxisome proliferator-activated receptor alpha and kinases. Biochemical Pharmacology 2000; 60: 1027–1032
- Lemberger T, Saladin R, Vazquez M, Assimacopoulos F, Staels B, Desvergne B, Wahli W, Auwerx J. Expression of the peroxisome proliferator-activated receptor alpha gene is stimulated by stress and follows a diurnal rhythm. Journal of Biological Chemistry 1996; 271: 1764–1769
- Lichtenstein AH, Kennedy E, Barrier P, Danford D, Ernst ND, Grundy SM, et al. Dietary fat consumption and health. Nutrition Reviews 1998; 56: 3–19
- Liu CH, Huang MT, Huang PC. Sources of triacylglycerol accumulation in livers of rats fed a cholesterol-supplemented diet. Lipids 1995; 30: 527–531
- Mandard S, Muller M, Kersten S. Peroxisome proliferator-activated receptor alpha target genes. Cellular and Molecular Life Sciences 2004; 61: 393–416
- Morazzoni P, Bombardelli E. Silybum marianum (Carduus marianus). Fitoterapia 1995; 66: 3–42
- Muerhoff AS, Griffin KJ, Johnson EF. The peroxisome proliferator-activated receptor mediates the induction of CYP4A6, a cytochrome P450 fatty acid omega-hydroxylase, by clofibric acid. Journal of Biological Chemistry 1992; 267: 19051–19053
- Schoonjans K, Staels B, Auwerx J. Role of the peroxisome proliferator activated receptor (PPAR) in mediating effects of fibrates and fatty acids on gene expression. Journal of Lipid Research 1996; 37: 907–925
- Šimánek V, Škottová N, Bartek J, Psotová J, Kosina P, Balejová L, Ulrichová J. Extract from Silybum marianum as nutraceutical: A double blind placebo-controlled study in healthy young men. Czech Journal of Food Sciences 2001; 19: 106–110
- Škottová N, Krečman V. Dietary silymarin improves removal of low density lipoproteins by the perfused rat liver. Acta Universitatis Palackianae Olomucensis Facultatis Medicinae 1998; 141: 39–40
- Škottová N, Krečman V, Váňa P, Chmela Z, Ulrichová J, Šimánek V. Effect of silymarin and silibinin–phosphatidylcholine complex on plasma and lipoprotein cholesterol, and oxidation of LDL in rats fed on high cholesterol diet supplemented with currant oil. Acta Universitatis Palackianae Olomucensis Facultatis Medicinae 2000; 144: 55–58
- Škottová N, Večeřa R, Urbánek K, Váňa P, Walterová D, Cvak L. Effects of polyphenolic fraction of silymarin on lipoprotein profile in rats fed cholesterol-rich diets. Pharmacological Research 2003; 47: 17–26
- Sobolová L, Škottová N, Večeřa R, Urbánek K. Effect of silymarin and its polyphenolic fraction on cholesterol absorbtion in rats. Pharmacological Research 2006; 53: 104–112
- Sørensen HN, Hvattum E, Paulssen EJ, Gautvik KM, Bremer J, Spydevold O. Induction of peroxisomal acyl-CoA oxidase by 3-thia fatty acid, in hepatoma cells and hepatocytes in culture is modified by dexamethasone and insulin. Biochimica et Biophysica Acta 1993; 1171: 263–271
- Sterchele PF, Sun H, Peterson RE, Vanden Heuvel JP. Regulation of peroxisome proliferator-activated receptor-alpha mRNA in rat liver. Archives of Biochemistry and Biophysics 1996; 326: 281–289
- Sumanasekera WK, Tien ES, Turpey R, Vanden Heuvel JP, Perdew GH. Evidence that peroxisome proliferator-activated receptor alpha is complexed with the 90-kDa heat shock protein and the hepatitis virus B X-associated protein 2. Journal of Biological Chemistry 2003; 278: 4467–4473
- Tirona RG, Kim RB. Nuclear receptors and drug disposition gene regulation. Journal of Pharmaceutical Sciences 2005; 94: 1169–1186
- Valenzuela A, Garrido A. Biochemical bases of the pharmacological action of the flavonoid silymarin and its structural isomer silibinin. Biological Research 1994; 27: 105–112
- van Raalte DH, Li M, Pritchard PH, Wasan KM. Peroxisome proliferator-activated receptor (PPAR)-alpha: A pharmacological target with a promising future. Pharmaceutical Research 2004; 21: 1531–1538
- Watts GF, Dimmitt SB. Fibrates, dyslipoproteinaemia and cardiovascular disease. Current Opinion in Lipidology 1999; 10: 561–574
- Xu HE, Lambert MH, Montana VG, Plunket KD, Moore LB, Collins JL, Oplinger JA, Kliewer SA, Gampe RT, Jr, McKee DD, et al. Structural determinants of ligand binding selectivity between the peroxisome proliferator-activated receptors. Proceedings of the National Academy of Sciences of the USA 2001; 98: 13919–13924